Arbutus Biopharma

In News

Arbutus Responds to Moderna’s Appeal of District Court Infringement Judgment over COVID Vaccines - JD Supra

JD Supra - Aug 06, 2026

Arbutus Biopharma Corporation (ABUS) Reports Q1 2026 Results - Yahoo Finance

Yahoo Finance - Jun 13, 2026

After $178M payoff from Moderna, Arbutus BioPharma expands patent litigation against Pfizer and BioNTech - The Business Journals

The Business Journals - Jul 16, 2026

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences - European AIDS Treatment Group

European AIDS Treatment Group - Apr 15, 2026

Arbutus Biopharma Corp expected to post a loss of 2 cents a share - Earnings Preview - TradingView

TradingView - Jul 31, 2026

Arbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - Jul 13, 2026

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B - GlobeNewswire

GlobeNewswire - Apr 15, 2026

Arbutus Biopharma (ABUS) Stock Looks Reasonable On Earnings But Stretched On Value - simplywall.st

simplywall.st - Jul 09, 2026

Arbutus Biopharma earnings beat by $0.91, revenue topped estimates - Investing.com

Investing.com - May 13, 2026

Arbutus Biopharma (ABUS): A Promising Biotech With Over 15% Potential Upside - DirectorsTalk Interviews

DirectorsTalk Interviews - Jul 24, 2026

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders - Yahoo Finance

Yahoo Finance - Jul 16, 2026

Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - May 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment